Below is a bookmarked list of the current clinical trials in the Upper Midwest Chapter territory sorted by area. If you're interested in any of the trials, please contact the person listed for more information.
Bismarck, ND | Des Moines, IA | Fargo, ND | Mayo Clinic Rochester | Minneapolis U of M | Minneapolis
|
Name of clinic |
MediciGlobal |
|
Name of study |
Study of Oral Teriflunomide (HMR1726) |
|
Name of doctor |
-- |
|
Purpose of study |
Recruiting People with Relapsing Forms of MS Worldwide. For further information, and to find out if this study is enrolling subjects at a site near you, please visit http://tower3.msstudies.com or call toll-free 1-866-565-0245. |
|
Contact |
1-866-565-0245 |
|
Name of clinic |
Mercy Ruan Neurology Clinic |
|
Name of study |
Allegro, Care MS, FTY720, CombiRX, Oracle, Tower, Tygris, Advance and Mosaic |
|
Name of doctor |
Vaires |
|
Purpose of study |
Vaires with each study |
|
Contact |
Val, 515-358-0002 |
|
Name of clinic |
Meticare MS Center |
|
Name of study |
CombiRx-Phase III, Tygris Study, Allegro Study, Allegro Extension Study, NEWS Study, Oracle MS Study and a collaborative study to characterize late-onset demyelinating disease |
|
Name of doctor |
Dr. Susan Scarberry |
|
Purpose of study |
Varies with each study |
|
Contact |
Peggy, 701-234-4036 |
|
Name of clinic |
Sanford Neuroscience |
|
Name of study |
Study of Oral Teriflunomide (HMR1726) |
|
Name of doctor |
|
|
Purpose of study |
Go to Patients like me web site for information |
|
Contact |
Tish, 701-234-4091 |
|
Name of clinic |
University of Minnesota MS Center |
|
Name of trial |
MRI Research Study |
|
Name of doctor |
Dr. Adam Carpenter |
|
Purpose of study |
The U of M is conducting a study to evaluate novel MRI sequences and compare them to conventional MRI's in MS patients and healthy controls. You may be eligible for this study if you have a diagnosis of MS or are a healthy control, are age 18 to 65, weigh under 250 pounds and can tolerate an MRI without sedation. |
|
Contact |
Clinical Neuroscience Research Unit at U of M, 612-626-5153 |
|
Minneapolis U of M |
|
|
Name of clinic |
University of Minnesota MS Center |
|
Name of trial |
Roche |
|
Name of doctor |
Dr. Adam Carpenter |
|
Purpose of study |
The University of Minnesota is conducting a study to determine whether an investigational treatment is safe and effective for Primary Progressive Multiple Sclerosis (PPMS). You may be eligible if you have a diagnosis of PPMS, are aged 18-55, inclusive and are able to undergo brain MRI scans. |
|
Contact |
Clinical Neuroscience Research Unit at U of M, 612-624-7745, cnru@umn.edu |
|
Minneapolis U of M |
|
|
Name of clinic |
University of Minnesota MS Center |
|
Name of trial |
MEG |
|
Name of doctor |
Dr. Adam Carpenter |
|
Purpose of study |
The University of Minnesota is conducting a study to better understand brain functions in patients with CIS or any form of MS. This is not a treatment study. You may be eligible for this study if you have a diagnosis of CIS or MS, are aged 18 to 75, and would be willing to undergo a brain scan. |
|
Contact |
Clinical Neuroscience Research Unit at U of M, 612-626-5133 |
|
Minneapolis U of M |
|
|
Name of clinic |
University of Minnesota MS Center |
|
Name of trial |
ACCLAIM |
|
Name of doctor |
Dr. Adam Carpenter |
|
Purpose of study |
The University of Minnesota is conducting a study to determine whether an investigational treatment is effective in preventing relapses in MS. You may be eligible if you have a diagnosis of relapsing-remitting MS, are aged 18 to 65, have had at least one relapse in the past year for which you sought medical attention or have had one or more gadolinium-enhanced MRI lesions in the past year. |
|
Contact |
Clinical Neuroscience Research Unit at U of M, 612-624-7745 |
|
Name of clinic |
Mayo Clinic |
|
Name of trial |
Aspirin Fatigue |
|
Name of doctor |
Dr. B Mark Keegan |
|
Purpose of study |
To study aspirin treatment for multiple sclerosis fatigue. You may be eligible if you are ambulatory without an aide, have had fatigue over eight weeks and are aged 18 to 65. |
|
Contact |
Darcy Rauchwarter, R.N., 507-284-9360 |
|
Name of clinic |
DaVita Clinical Rsearch Headquarters in Mineapolis |
|
Name of trial |
ELND002 |
|
Name of doctor |
Dr. Heather Muster |
|
Purpose of study |
To determine the safety and effectiveness of ELND002, a variation of an alpha-4-integrin inhibitor delivered via injection under the skin. A does-escalating, randomized, placebo-controlled, double blinded study to evaluate the safety and efficacy of subcutaneous ELND002. You may be eligible for this study if you have relapsing-remitting MS with documented medical history of relapse in the past year or MRI-documented evidence of MS activity in the past year. |
|
Contact |
Frank Terschan, 612-852-7006 |